XML 26 R8.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Cash flows from operating activities:      
Net income (loss) including noncontrolling interests in operating subsidiaries $ (54,799) $ (157,478) $ (66,662)
Adjustments to reconcile net income (loss) including noncontrolling interests in operating subsidiaries to net cash provided by (used in) operating activities:      
Depreciation and amortization 34,355 53,289 54,049
Non-cash stock compensation 9,062 11,048 18,115
Provision for deferred income taxes 0 0 (1,736)
Impairment of Patent-Related Intangible Assets 42,340 74,731 3,497
Impairment of Goodwill 0 30,149 0
Other (477) (109) (28)
Changes in assets and liabilities:      
Increase (Decrease) in Restricted Cash (787) (10,725) 0
Accounts receivable 6,750 (13,332) (13,827)
Prepaid expenses and other assets 1,593 (619) 3,154
Accounts payable and accrued expenses / costs (3,006) 2,570 3,718
Royalties and contingent legal fees payable (970) 527 3,904
Net cash provided by (used in) operating activities 34,061 (9,949) 4,184
Cash flows from investing activities:      
Purchase of property and equipment (4) (8) (109)
Purchase of available-for-sale investments (62,633) (23,296) (109,963)
Sale of available-for-sale investments 43,232 82,115 182,115
Patent acquisition costs (1,225) (19,504) (42,746)
Payments to Acquire Investments (20,000) 0 0
Net cash provided by (used in) investing activities (40,630) 39,307 29,297
Cash flows from financing activities:      
Payments of Dividends 0 (25,434) (25,039)
Distributions to noncontrolling interests in operating subsidiary (1,358) (4,105) (867)
Proceeds from the exercise of stock options 326 938 206
Repurchases of common stock (82) 0 0
Net cash provided by (used in) financing activities (1,114) (28,601) (25,700)
Increase in cash and cash equivalents (7,683) 757 7,781
Cash and cash equivalents, beginning 135,223 134,466 126,685
Cash and cash equivalents, ending 127,540 135,223 134,466
Patent acquisition costs included in accrued expenses $ 0 $ 1,000 $ 16,700